NIH-funded research Fellowship grant

Understanding how C. difficile spores sense signals to germinate and cause infection

Official title: Pseudoprotease-mediated regulation of germinant sensing in Clostridioides difficile

Funded at Tufts University Boston · NIH-10997790 · Data updated 2026-11-12

This study is looking at how Clostridioides difficile spores sense signals in the gut that make them wake up and cause infection, focusing on two special proteins that help with this process, which could lead to better ways to prevent or treat infections.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionTufts University Boston
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 1, 2024
Project endJanuary 31, 2028
Funding year2024
Award (this year)$45,162
NIH project number1F31AI186517-01
Project IDNIH-10997790 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced recurrent Clostridioides difficile infections or are at high risk for such infections.

Less likely to help

Patients who do not have a history of Clostridioides difficile infections or are not at risk for these infections may not benefit from this research.

What this research studies

This research investigates the mechanisms by which Clostridioides difficile spores detect specific signals in the gut that trigger their germination. The study focuses on two soluble pseudoproteases, CspA and CspC, which play crucial roles in sensing these signals and activating processes that lead to infection. By examining the interactions and structures of these proteins, the research aims to uncover how C. difficile integrates different signals to initiate germination. This understanding could provide insights into preventing or treating infections caused by this bacterium.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating Clostridioides difficile infections.

How similar studies have gone: Previous research has shown success in understanding germination mechanisms in other spore-forming bacteria, but the specific approach for C. difficile is relatively novel.

Where this research is happening

  • Tufts University Boston
    Boston, United States
    Active

Researchers

  • Principal investigator: Mcnellis, Morgan — Tufts University Boston
  • Study coordinator: Mcnellis, Morgan

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.